Longeveron Inc.
LGVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001721484
No open-market purchases or sales by Longeveron Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $3.35M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Longeveron Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +6 vs. Q1 2023
- Shares held
- 801.8K
- +378.2K (+89.3%) vs. Q1 2023
- Total value
- $2.71M
- +$1.58M (+139.7%) vs. Q1 2023
- New holders
- 8
- 5 more added
- Sold out
- 2
- 2 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LGVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $3.35M |
| Q1 2026 | 31 | $2.37M |
| Q4 2025 | 30 | $520.6K |
| Q3 2025 | 29 | $783.1K |
| Q2 2025 | 25 | $868.1K |
| Q1 2025 | 21 | $790.6K |
| Q4 2024 | 24 | $844.4K |
| Q3 2024 | 19 | $512.3K |
| Q2 2024 | 21 | $534.1K |
| Q1 2024 | 12 | $161.7K |
| Q4 2023 | 22 | $3.42M |
| Q3 2023 | 19 | $1.37M |
| Q2 2023 | 21 | $2.71M |
| Q1 2023 | 16 | $1.13M |
| Q4 2022 | 17 | $1.45M |
| Q3 2022 | 18 | $1.64M |
| Q2 2022 | 14 | $2.24M |
| Q1 2022 | 14 | $9.59M |
| Q4 2021 | 19 | $5.55M |
| Q3 2021 | 13 | $1.07M |
| Q2 2021 | 12 | $2.96M |
| Q1 2021 | 10 | $561.0K |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Longeveron Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 184,346 | $623.1K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 112,321 | $379.6K | 0.00% | +2,052+1.9% | Added |
| Creative Planning | 109,322 | $369.5K | 0.00% | +109,322 | New |
| Yakira Capital Management, Inc. | 85,000 | $287.3K | 0.08% | +85,000 | New |
| Boothbay Fund Management, LLC | 75,000 | $253.5K | 0.01% | +75,000 | New |
| Alpine Global Management, LLC | 75,000 | $253.5K | 0.07% | +75,000 | New |
| Geode Capital Management, LLC | 66,392 | $224.4K | 0.00% | +29,212+78.6% | Added |
| Susquehanna International Group, LLP | 18,513 | $62.6K | 0.00% | +18,513 | New |
| State Street Corp | 14,800 | $50.0K | 0.00% | 00.0% | Unchanged |
| TownSquare Capital, LLC | 14,450 | $48.8K | 0.00% | 00.0% | Unchanged |
| Sea Otter Advisors LLC | 13,416 | $45.3K | 0.04% | +13,416 | New |
| Schonfeld Strategic Advisors LLC | 12,800 | $43.3K | 0.00% | +200+1.6% | Added |
| Northern Trust Corp | 10,623 | $35.9K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,811 | $19.6K | 0.00% | +3,782+186.4% | Added |
| Bank of America Corp | 2,774 | $9.38K | 0.00% | −2,100−43.1% | Reduced |
| Morgan Stanley | 700 | $2.37K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 220 | $744 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 129 | $436 | 0.00% | −4,279−97.1% | Reduced |
| Wells Fargo & Company | 41 | $139 | 0.00% | +3+7.9% | Added |
| JPMorgan Chase & Co | 21 | $71 | 0.00% | +21 | New |
| Royal Bank of Canada | 87 | $0 | 0.00% | +87 | New |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −24,992−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Householder Group Estate & Retirement Specialist, LLC | – | – | – | – | Not filed |